Literature DB >> 10027333

Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers.

R Palmqvist1, P Sellberg, A Oberg, B Tavelin, J N Rutegård, R Stenling.   

Abstract

The conflicting results about the prognostic impact of tumour cell proliferation in colorectal cancer might be explained by the heterogeneity observed within these tumours. We have investigated whether a systematic spatial heterogeneity exists between different compartments, and whether the presence of such a systematic heterogeneity has any impact on survival. Fifty-six Dukes' stage B colorectal cancers were carefully morphometrically quantified with respect to the immunohistochemical expression of the proliferative marker Ki-67 at both the luminal border and the invasive margin. The proliferative activity was significantly higher at the luminal border compared with the invasive margin (P<0.001), although the two compartments were also significantly correlated with each other. Tumours with low proliferation at the invasive margin had a significantly poorer prognosis both in univariate (P = 0.014) and in multivariate survival analyses (P = 0.042). We conclude that Dukes' B colorectal cancers exhibit a systematic spatial heterogeneity with respect to proliferation, and tumours with low proliferation at the invasive margin had a poor prognosis. The present data independently confirm recent results from the authors, and provide new insights into the understanding of tumour cell proliferation in colorectal cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10027333      PMCID: PMC2362413          DOI: 10.1038/sj.bjc.6690091

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Heterogeneity of DNA distribution pattern in colorectal carcinoma. A microspectrophotometric study of fine needle aspirates.

Authors:  M Koha; T O Caspersson; B Wikström; B Brismar
Journal:  Anal Quant Cytol Histol       Date:  1990-10       Impact factor: 0.302

Review 2.  Some new, simple and efficient stereological methods and their use in pathological research and diagnosis.

Authors:  H J Gundersen; T F Bendtsen; L Korbo; N Marcussen; A Møller; K Nielsen; J R Nyengaard; B Pakkenberg; F B Sørensen; A Vesterby
Journal:  APMIS       Date:  1988-05       Impact factor: 3.205

3.  Bile acids and the increased risk of colorectal tumours after truncal vagotomy.

Authors:  F J Mullan; H K Wilson; C W Majury; J O Mills; A J Cromie; G R Campbell; S T McKelvey
Journal:  Br J Surg       Date:  1990-10       Impact factor: 6.939

4.  Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas.

Authors:  S P Harlow; B L Eriksen; L Poggensee; J S Chmiel; D G Scarpelli; T Murad; K D Bauer
Journal:  Cancer Res       Date:  1991-05-01       Impact factor: 12.701

5.  Comparison of proliferative activities and metastases between two subtypes classified at the deeply infiltrating sites of colorectal moderately differentiated adenocarcinomas.

Authors:  K Taniyama; N Sasaki; S Wada; M Sasaki; N Miyoshi; H Nakai; S Kodama; H Nakatsuka; E Tahara
Journal:  Pathol Int       Date:  1996-03       Impact factor: 2.534

6.  [Influence of rectal preparation by enema on cell proliferation in the normal rectal mucosa in man].

Authors:  T Lehy; J L Abitbol; M Mignon
Journal:  Gastroenterol Clin Biol       Date:  1984-03

7.  Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations.

Authors:  N A Shepherd; P I Richman; J England
Journal:  J Pathol       Date:  1988-07       Impact factor: 7.996

8.  DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma.

Authors:  T E Witzig; C L Loprinzi; N J Gonchoroff; H M Reiman; S S Cha; H S Wieand; J A Katzmann; J K Paulsen; C G Moertel
Journal:  Cancer       Date:  1991-08-15       Impact factor: 6.860

9.  Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas.

Authors:  G Lindmark; B Glimelius; L Påhlman; P Enblad
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

10.  The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma.

Authors:  P A Hall; M A Richards; W M Gregory; A J d'Ardenne; T A Lister; A G Stansfeld
Journal:  J Pathol       Date:  1988-03       Impact factor: 7.996

View more
  17 in total

1.  High-level mRNA quantification of proliferation marker pKi-67 is correlated with favorable prognosis in colorectal carcinoma.

Authors:  Thomas Ihmann; Jian Liu; Wolfgang Schwabe; Peter Häusler; Detlev Behnke; Hans-Peter Bruch; Rainer Broll; Ute Windhövel; Michael Duchrow
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-21       Impact factor: 4.553

2.  Imunoexpression of Ki-67 and p53 in rectal cancer tissue after treatment with neoadjuvant chemoradiation.

Authors:  Nara Rosana Andrade; Celina Tizuko Fujiyama Oshima; Thiago Simão Gomes; Ricardo Artigiani Neto; Nora Manoukian Forones
Journal:  J Gastrointest Cancer       Date:  2011-03

3.  Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer.

Authors:  Eeva Salminen; Salla Palmu; Tero Vahlberg; Peter-J Roberts; Karl-Owe Söderström
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

4.  The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation.

Authors:  A Jung; M Schrauder; U Oswald; C Knoll; P Sellberg; R Palmqvist; G Niedobitek; T Brabletz; T Kirchner
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

5.  Assessment of SMAD4, p53, and Ki-67 alterations as a predictor of liver metastasis in human colorectal cancer.

Authors:  Masayo Kawakami; Tatsuro Yamaguchi; Keiichi Takahashi; Hiroshi Matsumoto; Michiya Yasutome; Shinichiro Horiguchi; Yukiko Hayashi; Nobuaki Funata; Takeo Mori
Journal:  Surg Today       Date:  2010-02-24       Impact factor: 2.549

Review 6.  [Current status of the prognostic value of molecular markers in patients with colorectal cancer and the prediction of response to adjuvant therapy].

Authors:  Jose M Fernández-Cebrián; Peter Vorwald Kuborn; Mar Pardo de Lama; Alfonso Sanjuanbenito Dehesa; Manuel Nevado Santos; Pedro A Pacheco Martínez; Beatriz Fernández-Escudero
Journal:  Clin Transl Oncol       Date:  2005-04       Impact factor: 3.405

7.  Crude extract of Jatobá leaves promotes canine osteosarcoma cell D17 proliferation.

Authors:  V S Vieira; V S Cruz; L L Nepomuceno; N P Soares; E Arnhold; W F P Teixeira; D S Vieira; J C A Borges; F M Paixão; E G Araújo
Journal:  Vet World       Date:  2022-05-24

8.  Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study.

Authors:  Annelies Debucquoy; Laurence Goethals; Louis Libbrecht; Christiaan Perneel; Karel Geboes; Nadine Ectors; William H McBride; Karin Haustermans
Journal:  Int J Colorectal Dis       Date:  2008-12-03       Impact factor: 2.571

9.  In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography.

Authors:  D L Francis; A Freeman; D Visvikis; D C Costa; S K Luthra; M Novelli; I Taylor; P J Ell
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

10.  Slow proliferation as a biological feature of colorectal cancer metastasis.

Authors:  A Anjomshoaa; S Nasri; B Humar; J L McCall; A Chatterjee; H-S Yoon; L McNoe; M A Black; A E Reeve
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.